Washington Dc, DCNCT06412666Now EnrollingIRB Ready

Hypertrophic Cardiomyopathy Clinical Trial in Washington Dc, DC

Access cutting-edge hypertrophic cardiomyopathy treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.

Sponsored by Cytokinetics

Quick Self-Assessment

See if you qualify for this Washington Dc location

Preparing your pre-screening questions...

Expert Care in Washington Dc

Access hypertrophic cardiomyopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hypertrophic cardiomyopathy treatment provided free

Apply for This Washington Dc Location

Check if you qualify for this hypertrophic cardiomyopathy clinical trial in Washington Dc, DC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Washington Dc

    Convenient for DC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Washington Dc site if eligible
  4. 4Begin participation

About This Hypertrophic Cardiomyopathy Study in Washington Dc

The purpose of this study is to evaluate the efficacy, safety and PK of aficamten in a pediatric population with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).

Sponsor: Cytokinetics

Who Can Participate

Inclusion Criteria

Period 1: Treatment Period
Males and females between 12 and \< 18 years of age at screening and at Day 1.
Body weight ≥ 45 kg for the initial cohort and then body weight ≥ 35 kg after at least 10 participants in the initial cohort have undergone dose titration up to Week 4 without observed events of LVEF \< 50% at the starting dose of 5 mg qd.
Core laboratory confirmation of the following oHCM echocardiographic criteria at screening:
Left ventricular (LV) hypertrophy with nondilated LV chamber in the absence of other cardiac disease.
LV end-diastolic wall thickness that meets a threshold of:
Z-score \> 2.5 in the absence of family history OR
Z-score \> 2 in the presence of positive family history or positive genetic test.
LVEF ≥ 60% AND Valsalva LVOT-G ≥ 50 mmHg.
oHCM of sarcomeric origin confirmed by genetic testing or, if unable to confirm by genetic testing, oHCM of sarcomeric origin may be presumed in the absence of history of

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Washington Dc?

Yes, this clinical trial (NCT06412666) has an active research site in Washington Dc, DC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hypertrophic Cardiomyopathy Treatment Options in Washington Dc, DC

If you're searching for hypertrophic cardiomyopathy treatment options in Washington Dc, DC, this clinical trial (NCT06412666) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypertrophic cardiomyopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hypertrophic cardiomyopathy clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Washington Dc, DC

See all pulmonary embolism clinical trials recruiting in Washington Dc — not just this study.

Browse Pulmonary Embolism Trials in Washington Dc →

Browse More Trials by Condition

Pulmonary Embolism TrialsCardiomyopathy TrialsPulmonary Hypertension TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Washington Dc?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Washington Dc, DC